A recent study indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who end conventional diet and exercise programs.
Published data in a leading medical journal shows that while overweight individuals often shed substantial amounts of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.
"Individuals using such medications should be informed of the potential of quick rebound weight gain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery means a return to original weight within about 18 months.
Weighing Therapies
The analysis, which examined dozens of trials involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.
Researchers point out that individuals who lose weight through dieting typically have a slower creep back—around 100 grams monthly—after stopping.
The Reason for the Rapid Regain
Nutrition scientists suggest the mode of action of the injections is key to understanding the heightened rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means hunger is unsuppressed, making overeating far more likely."
An Ongoing Disease?
Medical guidelines suggest the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts contend that, considering the high risk of weight regain, the treatment is often long-term.
This opinion is supported by pharmaceutical companies, who note that the findings "emphasize the long-term character of obesity," akin to managing diseases like hypertension.
User Testimonies
Users who have come off the medication report a powerful resurgence of cravings.
"It felt as if something activating and I was suddenly extremely hungry," recalled an individual.
The struggle is compounded if users have not established lasting lifestyle or habit modifications during treatment.
Widespread Interest
Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with desire remaining high.
- Use is greater among women than men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and maintained weight loss hinges on ongoing behavioural management.
